Abstract
This overview follows on from part I, which described the current practices used in chemotherapy dosing and the paucity of scientific evidence to support them. In part II, alternative approaches are discussed, both in terms of scientific rationale and practical application. These include therapeutic drug monitoring, the use of pharmacokinetic-pharmacodynamic relationships, flat-fixed dosing, Bayesian modelling and dose banding.
Original language | English |
---|---|
Pages (from-to) | 99-107 |
Number of pages | 9 |
Journal | Clinical Oncology |
Volume | 19 |
Issue number | 2 |
DOIs | |
Publication status | Published - Mar 2007 |